Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! Please be sure to document all clinical activities daily.
Symfi Lo: Inpatients to use home supply. Efavirenz 200 mg is no longer commercially available. If home supply is not available, utilize therapeutic interchange with efavirenz 300 mg dosage until the home supply is acquired.
Symfi Lo: Inpatients to use home supply. Efavirenz 200 mg is no longer commercially available. If home supply is not available, utilize therapeutic interchange with efavirenz 300 mg dosage until the home supply is acquired.
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
(Symfi)
efavirenz (Sustiva) and lamiVUDine (Epivir) and tenofovir disoproxil fumarate (Viread)
(Symfi Lo)
efavirenz (Sustiva) and lamiVUDine (Epivir) and tenofovir disoproxil fumarate (Viread)
Symfi and Symfi Lo are non-formulary. Automatic interchange to equivalent single drug products.
Reviewed: 28 Aug 2018 (Symfi & Symfi Lo), February 2025 (Symfi Lo)
Efavirenz-lamiVUDine-tenofovir disoproxil fumarate (Symfi Lo) Formulary Update